Literature DB >> 26893644

Proton pump inhibitor-induced exfoliative dermatitis: A case report.

Zhihong Qiu1, Hongtao Liu1, Lien He1, Yinling Ma1, Haojing Song1, Wanjun Bai1, Meiling Yu2.   

Abstract

A 74-year-old female patient was admitted to hospital following a road accident with pains in the chest, abdomen, waist, back, nose, left wrist and lower limbs. After 1 week, the patient presented with gastrointestinal bleeding, and thus was treated with protein pump inhibitors (PPIs), including lansoprazole, esomeprazole and omeprazole enteric-coated tablets, in order to inhibit acid secretion and attenuate bleeding. However, the patient developed skin rashes on the chest and right lower limb and foot 28 days following treatment initiation. The skin rashes spread and ulcerated after 3 days, and were associated with tracheal mucosal injury and hemoptysis. Subsequently, treatment of the patient with PPIs was terminated, after which the tracheal hemoptysis and skin rashes markedly improved. In addition, no new skin rashes appeared following termination of the PPI treatment. In the present case, long-term treatment of an elderly patient with PPIs may have induced exfoliative dermatitis, due to hepatic ischemia, hypoxia and acute renal failure, which may have decreased the metabolism of PPIs, resulting in the accumulation of PPI metabolites.

Entities:  

Keywords:  exfoliative dermatitis; proton pump inhibitors

Year:  2015        PMID: 26893644      PMCID: PMC4733946          DOI: 10.3892/etm.2015.2926

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  21 in total

1.  [Gastroesophageal reflux and proton pump inhibitors: panacea or prescription abuse?].

Authors:  O Mouterde; M Bellaïche; C Dumant; E Mallet
Journal:  Arch Pediatr       Date:  2010-06       Impact factor: 1.180

2.  Exfoliative dermatitis to all four first line oral anti-tubercular drugs.

Authors:  Ruchi Dua; Girish Sindhwani; Jagdish Rawat
Journal:  Indian J Tuberc       Date:  2010-01

3.  Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19.

Authors:  Tatyana Zvyaga; Shu-Ying Chang; Cliff Chen; Zheng Yang; Ragini Vuppugalla; Jeremy Hurley; Denise Thorndike; Andrew Wagner; Anjaneya Chimalakonda; A David Rodrigues
Journal:  Drug Metab Dispos       Date:  2012-05-30       Impact factor: 3.922

4.  Reaction of proton pump inhibitors with model peptides results in novel products.

Authors:  Charles Watson; Lixin Zhu; Shenheng Guan; Terry E Machen; John G Forte
Journal:  J Pharmacol Sci       Date:  2013       Impact factor: 3.337

5.  Proton pump inhibitors: Are we still prescribing them without valid indications?

Authors:  Farooq Akram; Yufang Huang; Valencia Lim; Paul J Huggan; Reshma A Merchant
Journal:  Australas Med J       Date:  2014-11-30

6.  Erythroderma in adults: a report of 80 cases.

Authors:  Benmously Mlika Rym; Mokni Mourad; Zouari Bechir; Eleuch Dalenda; Cherif Faika; Azaiz Mohamed Iadh; Ben Osman-Dhahri Amel
Journal:  Int J Dermatol       Date:  2005-09       Impact factor: 2.736

Review 7.  Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.

Authors:  T Andersson
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

Review 8.  Hypersensitivity reactions to proton pump inhibitors.

Authors:  Yoon-Seok Chang
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-08

9.  Proton pump inhibitor prescribing and costs in a large outpatient clinic.

Authors:  William Hood; Brittain McJunkin; Alicia Warnock; Aditi Girme; Nelson Smith; Brandon Robinson
Journal:  W V Med J       Date:  2014 Jan-Feb

10.  Disseminated exfoliative dermatitis associated with all-transretinoic Acid in the treatment of acute promyelocytic leukemia.

Authors:  Yonal Ipek; Dogru Hulya; Aktan Melih
Journal:  Case Rep Med       Date:  2012-07-17
View more
  2 in total

1.  Proton Pump Inhibitors and Infection-Related Hospitalizations Among Residents of Long-Term Care Facilities: A Case-Control Study.

Authors:  Kate N Wang; J Simon Bell; Edwin C K Tan; Julia F M Gilmartin-Thomas; Michael J Dooley; Jenni Ilomäki
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

2.  Severe adverse reactions caused by omeprazole: A case report.

Authors:  Meiling Yu; Jianghua Qian; Daohua Guo; Li Li; Xiaolin Liu
Journal:  Exp Ther Med       Date:  2016-06-08       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.